Treventis CSO Mark Reed was in attendance at the 8th Neurodegenerative Drug […]

Treventis VP Research Marcia Taylor has attended Tau2020 in Washington, DC, which […]

Treventis founders Dr. Donald Weaver, Mark Reed, and Christopher Barden have supervised […]

Treventis CEO Christopher Barden attended BioPort, Atlantic Canada’s largest health and life […]

Treventis CSO Mark Reed attended the Texas Life Science Forum on November […]

CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he […]

Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, […]

Treventis CEO Christopher Barden was honored to be an invited speaker at […]

Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine […]

Treventis was well represented at the Alzheimer Association International Conference, running from […]